Posts Archive

SABLe NCT04717700: Phase 2: Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients...

MCRT Webcast - Myeloma Crowd Round Table Myeloma Crowd Round Tables program MCRT Webcast Apr 10, 2021 Overview of BCMA & Other Targets in...

MAGNETISMM-2 NCT04798586: Phase 1: MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma...

NCT04722146: Phase 1b - Teclistamab With Other Anticancer Therapies in Participants With Myeloma Newly Diagnosed Multiple Myeloma...

NCT04850846: Phase 2: Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma Investigation of...

THE MMRF - Managing Myeloma Resource Brochure Click here to download Learn more: Multiple Myeloma Research Foundation Education Programs...

THE MMRF - Multiple Myeloma Treatment Overview Click here to download Learn more: Multiple Myeloma Research Foundation Education Programs...

NCCN GUIDELINES FOR PATIENTS: Immunotherapy Side Effects: CAR T-Cell Therapy https://www.nccn.org/patients/guidelines/content/PDF/immunot...

NCT04892446: Phase 2: Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma NCT04892446: Phase 2:...

NUTRIVENTION Study NCT04920084: A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or...

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma The purpose of...

THE MMRF - Multiple Myeloma Disease Overview Click here to download Learn more: Multiple Myeloma Research Foundation Education Programs...

The Binding Site: Introducing the iStopMM Trial The Binding Site: Introducing the iStopMM Trial Learn more: The Binding Site...

Phase 1 Relapsed & Refractory Myeloma A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma The...

NCT04827563: Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib Observational Dyspnea and Cardiotoxicity in...

Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma Relapsed & Refractory Myeloma NCT04822337:...

Anti-BCMA/Anti-CD3 Bispecific Antibody EMB-06 NCT04735575: Phase 1/2: Study of EMB-06 in Participants With Relapsed or Refractory Myeloma...

NCT04855929: Phase 1: A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer and Multiple Myeloma....

NCT04814615: Phase 2: A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma NCT04814615: Phase 2: A Diagnostic Study of CD38-Targeted...

THE MMRF - Multiple Myeloma Caregiver Guide Click here to download Learn more: Multiple Myeloma Research Foundation Education Programs...

MCRT Webcast - Myeloma Crowd Round Table Myeloma Crowd Round Tables program Myeloma Crowd by HealthTree MCRT Webcast Jan 30, 2021 ASH...

HealthTree University Myeloma: What are the different catheters and ports? HealthTree University Myeloma: What are the different...

Watch on YouTube Current and Future Treatment of Multiple Myeloma Jan 19, 2021 Dana-Farber Cancer Institute https://www.dana-farber.org/m...

NCT04688853: Phase 1 - A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients This is...